Or. Admin. R. 333-010-0060 - Cancer Reporting Regulations: Special Studies

(1) From time to time, OSCaR may elect to conduct special studies of cancer mortality, morbidity, treatment options and cancer control. OSCaR is specifically authorized to obtain any information which may apply to a patient's reportable cancer or reportable non-malignant condition, and which may be found in the medical record of the patient under ORS 432.510 and 432.520. Upon request, the practitioner or health care facility must provide the requested information to OSCaR or provide OSCaR personnel access to the relevant portions of the medical records. Neither OSCaR nor the record holder shall bill the other for the cost of providing or obtaining this information.
(2) If, in the conduct of a special study, OSCaR identifies a need for access to pathological specimens that have been collected in connection with a case, OSCaR must make a written request to the clinical laboratory or the health care facility with which the clinical laboratory is affiliated for the purpose of making arrangements for the procurement of such pathological specimens upon mutually agreeable terms.


Or. Admin. R. 333-010-0060
HD 2-1996, f. & cert. ef. 2-29-96; PH 13-2011, f. 12-28-11, cert. ef. 1-1-12; PH 20-2017, amend filed 12/21/2017, effective 1/1/2018

Statutory/Other Authority: ORS 432.510 & 432.520

Statutes/Other Implemented: ORS 432.510 & 432.520

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.